• $6,165.00
    Market Cap
  • -75.00%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
09/30/2024
09/30/2023
09/30/2022
09/30/2021
Income Statement
Total Operating Revenue
0
N/A
0
N/A
N/A
N/A
0
N/A
Cost of Revenue
0
N/A
0
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
747,776
-67.66%
2.3M
+95.71%
1.2M
-56.22%
2.7M
+225.61%
Research and Development Expense
-153,898
-0.30%
-154,362
-17.06%
-186,115
N/A
N/A
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
2,092
+337.66%
Total Operating Expenses
901,674
-63.45%
2.5M
+80.37%
1.4M
-49.33%
2.7M
+225.61%
Operating Profit
-901,674
-63.45%
-2.5M
+80.37%
-1.4M
-49.33%
-2.7M
+225.61%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
-1.2M
-27.80%
-1.7M
+348.42%
-377,871
+1,137.46%
Interest Income and Expense and Net
0
+100.00%
-1.2M
-27.80%
-1.7M
+348.42%
-377,871
+1,137.46%
Total Nonoperating Income and Expense
-1.8M
-22.23%
-2.3M
+548.33%
-348,310
-286.80%
186,465
+103.03%
Income before Taxes
-2.7M
-44.27%
-4.8M
+248.71%
-1.4M
-49.33%
-2.7M
+225.61%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-2.7M
-43.75%
-4.7M
+175.35%
-1.7M
-31.70%
-2.5M
-62.89%
Net Income from Continuing Operations Applicable to Common
-2.7M
-44.27%
-4.8M
+177.93%
-1.7M
-31.70%
-2.5M
-64.06%
Basic EPS and Net Income
-0.06
-73.91%
-0.23
+130.00%
-0.10
-54.55%
-0.22
-94.79%
Diluted EPS and Net Income
-0.06
-73.91%
-0.23
+130.00%
-0.10
-54.55%
-0.22
-94.79%
Basic Weighted Average Shares
44.6M
+114.28%
20.8M
+26.03%
16.5M
+46.77%
11.3M
+602.20%
Diluted Weighted Average Shares
44.6M
+114.28%
20.8M
+26.03%
16.5M
+46.77%
11.3M
+602.20%
Balance Sheet
Cash and Cash Equivalents
20,891
-2.45%
21,415
-66.67%
64,251
-64.44%
180,668
+101,398.88%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
20,891
-2.45%
21,415
-66.67%
64,251
-64.44%
180,668
+101,398.88%
Total Current Assets
62,224
-0.04%
62,248
-50.16%
124,901
-39.88%
207,754
+116,615.73%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
62,224
-0.04%
62,248
-50.16%
124,901
-39.99%
208,134
+116,829.21%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
2.2M
+0.79%
2.2M
+50.13%
1.5M
+552.49%
224,578
+14.40%
Total Current Liabilities
10.1M
+28.31%
7.9M
+64.52%
4.8M
+20.34%
4.0M
+14.92%
Total Long-Term Debt
88,111
-98.57%
6.2M
N/A
0
-100.00%
165,880
+44.24%
Total Long-Term Liabilities
3.4M
+13.76%
3.0M
N/A
0
-100.00%
165,880
+44.24%
Total Liabilities
10.1M
+28.31%
7.9M
+64.52%
4.8M
+15.52%
4.1M
+15.86%
Retained Earnings
-69.6M
+3.97%
-66.9M
+7.60%
-62.2M
+2.84%
-60.5M
+4.34%
Total Stockholders Equity
-10.0M
+28.53%
-7.8M
+67.60%
-4.7M
+18.46%
-3.9M
+10.04%
Total Shares Outstanding
61.7M
+183.53%
21.7M
+16.47%
18.7M
+29.61%
14.4M
+798.29%
Cash Flow
Cash from Operating Activities
-215,402
-65.52%
-624,636
-30.86%
-903,489
+32.41%
-682,333
+632.20%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
0
N/A
N/A
N/A
N/A
N/A
0
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
214,878
-63.07%
581,800
-26.08%
787,072
-8.78%
862,823
+910.34%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-4,270.66%
-15.42%
-5,049.39%
+390.00%
-1,030.50%
-57.28%
-2,412.22%
-61.63%
Return on Equity
29.83%
-60.70%
75.89%
+89.76%
39.99%
-40.32%
67.02%
-71.26%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.006
-21.52%
0.008
-69.73%
0.03
-50.10%
0.05
+52,200.00%
Cash Ratio
0.002
-22.22%
0.003
-79.85%
0.01
-70.55%
0.05
+45,400.00%
Debt-to-Equity Ratio
-0.23
-78.56%
-1.07
+240.68%
-0.31
+216.80%
-0.10
+13.99%
Debt-to-Assets Ratio
37.05
-72.43%
134.40
+1,045.60%
11.73
+525.37%
1.88
-99.89%

Earnings & Revenue History

Debt-to-Assets

Cash Flow